A. Costanzo, “Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study”, Acta Derm Venereol, vol. 101, no. 10, p. adv00576, Oct. 2021.